Propanc Biopharma, Inc.
PPCB· Nasdaq
PPCBPropanc Biopharma, Inc.
Filed Feb 16, 2016 · 10-Q · 47 days after period end · 0001144204-16-082302
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Net Income | -$3.56M | -$345.48K | $26.40K | -$387.75K |
| EPS Diluted | -$0.01 | $0.00 | $0.00 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Propanc Biopharma, Inc. · CIK 1517681 · Engraved from SEC EDGAR
ended Dec 31, 2015 · filed Feb 16, 2016 · 47 d after period end
